Lanka Hospitals Corp. Plc
CCSELK:LHCL.N0000102.00
LKR
-7.50
(-6.85%)
Lanka Hospitals Corp. Plc
CSELK:LHCL.N0000
(Colombo Stock Exchange)
Recent
price
102.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- The Lanka Hospitals Corporation PLC is a Sri Lanka-based tertiary healthcare service provider that owns and operates multi-specialty hospitals and diagnostic laboratories. Established in 2002 and headquartered in Colombo, Sri Lanka, the company delivers comprehensive inpatient, outpatient, surgical, emergency, and diagnostic medical services to domestic and international patients. The company operates primarily through two core business segments: Hospital Services and Diagnostic Services. Its medical and surgical portfolio includes cardiology and cardiothoracic surgery; medical and surgical oncology; neurology and neurosurgery; nephrology, hemodialysis, and renal transplantation; orthopedics, sports medicine, and joint replacement; gastroenterology and hepatology; obstetrics, gynecology, and specialized maternal-fetal care; general, laparoscopic, and bariatric surgery; pediatric medicine and neonatal intensive care; cosmetic and reconstructive dermatology; and round-the-clock emergency and critical care. The company operates dedicated centers of excellence, including the Lanka Hospitals Heart Centre, the Lanka Hospitals Fertility Centre offering in vitro fertilization (IVF) and assisted reproductive technology, the Renal Care Centre, the Gastroenterology Centre, and executive wellness clinics. Through its subsidiary, Lanka Hospitals Diagnostics (Pvt) Ltd, the company offers clinical laboratory services spanning clinical chemistry, hematology, microbiology, histopathology, molecular diagnostics, genetics, and flow cytometry across an extensive network of regional laboratories and specimen collection centers nationwide. Its diagnostic imaging portfolio encompasses magnetic resonance imaging (MRI), multi-slice computed tomography (CT), digital radiography, 3D/4D ultrasound, digital mammography, and interventional radiology. Complementary offerings include retail and inpatient pharmacy operations, physiotherapy and physical rehabilitation, dental care, and corporate health screening packages. In recent strategic and corporate developments, Lanka Hospitals Corporation PLC has been subject to the Government of Sri Lanka's State-Owned Enterprise (SOE) restructuring program, with the Ministry of Finance's State-Owned Enterprises Restructuring Unit facilitating a competitive divestment process for the majority state-held equity stake held through Sri Lanka Insurance Corporation. Operationally, the company has continued to expand its diagnostic laboratory footprint by opening new collection facilities across Sri Lanka, invested in advanced minimally invasive surgical equipment and upgraded diagnostic imaging suites, and expanded its digital healthcare and telemedicine service infrastructure while maintaining international quality accreditations including Joint Commission International (JCI) accreditation and College of American Pathologists (CAP) accreditation.